1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Varicella-Zoster Virus (VZV) Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Acyclovir 1.2.3 Valacyclovir 1.2.4 Famciclovir 1.2.5 Others 1.3 Market by Application 1.3.1 Global Varicella-Zoster Virus (VZV) Treatment Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital Pharmacies 1.3.3 Retail Pharmacies 1.3.4 Online Pharmacies 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Varicella-Zoster Virus (VZV) Treatment Market Perspective (2016-2027) 2.2 Varicella-Zoster Virus (VZV) Treatment Growth Trends by Regions 2.2.1 Varicella-Zoster Virus (VZV) Treatment Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Varicella-Zoster Virus (VZV) Treatment Historic Market Share by Regions (2016-2021) 2.2.3 Varicella-Zoster Virus (VZV) Treatment Forecasted Market Size by Regions (2022-2027) 2.3 Varicella-Zoster Virus (VZV) Treatment Industry Dynamic 2.3.1 Varicella-Zoster Virus (VZV) Treatment Market Trends 2.3.2 Varicella-Zoster Virus (VZV) Treatment Market Drivers 2.3.3 Varicella-Zoster Virus (VZV) Treatment Market Challenges 2.3.4 Varicella-Zoster Virus (VZV) Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Varicella-Zoster Virus (VZV) Treatment Players by Revenue 3.1.1 Global Top Varicella-Zoster Virus (VZV) Treatment Players by Revenue (2016-2021) 3.1.2 Global Varicella-Zoster Virus (VZV) Treatment Revenue Market Share by Players (2016-2021) 3.2 Global Varicella-Zoster Virus (VZV) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Varicella-Zoster Virus (VZV) Treatment Revenue 3.4 Global Varicella-Zoster Virus (VZV) Treatment Market Concentration Ratio 3.4.1 Global Varicella-Zoster Virus (VZV) Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Varicella-Zoster Virus (VZV) Treatment Revenue in 2020 3.5 Varicella-Zoster Virus (VZV) Treatment Key Players Head office and Area Served 3.6 Key Players Varicella-Zoster Virus (VZV) Treatment Product Solution and Service 3.7 Date of Enter into Varicella-Zoster Virus (VZV) Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Varicella-Zoster Virus (VZV) Treatment Breakdown Data by Type 4.1 Global Varicella-Zoster Virus (VZV) Treatment Historic Market Size by Type (2016-2021) 4.2 Global Varicella-Zoster Virus (VZV) Treatment Forecasted Market Size by Type (2022-2027) 5 Varicella-Zoster Virus (VZV) Treatment Breakdown Data by Application 5.1 Global Varicella-Zoster Virus (VZV) Treatment Historic Market Size by Application (2016-2021) 5.2 Global Varicella-Zoster Virus (VZV) Treatment Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Varicella-Zoster Virus (VZV) Treatment Market Size (2016-2027) 6.2 North America Varicella-Zoster Virus (VZV) Treatment Market Size by Type 6.2.1 North America Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2021) 6.2.2 North America Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2022-2027) 6.2.3 North America Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2027) 6.3 North America Varicella-Zoster Virus (VZV) Treatment Market Size by Application 6.3.1 North America Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2021) 6.3.2 North America Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2022-2027) 6.3.3 North America Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2027) 6.4 North America Varicella-Zoster Virus (VZV) Treatment Market Size by Country 6.4.1 North America Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2016-2021) 6.4.2 North America Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Varicella-Zoster Virus (VZV) Treatment Market Size (2016-2027) 7.2 Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Type 7.2.1 Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2021) 7.2.2 Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2022-2027) 7.2.3 Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2027) 7.3 Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Application 7.3.1 Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2021) 7.3.2 Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2022-2027) 7.3.3 Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2027) 7.4 Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Country 7.4.1 Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2016-2021) 7.4.2 Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size (2016-2027) 8.2 Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Type 8.2.1 Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2027) 8.3 Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Application 8.3.1 Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2027) 8.4 Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Region 8.4.1 Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Varicella-Zoster Virus (VZV) Treatment Market Size (2016-2027) 9.2 Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Type 9.2.1 Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2021) 9.2.2 Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2022-2027) 9.2.3 Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2027) 9.3 Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Application 9.3.1 Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2021) 9.3.2 Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2022-2027) 9.3.3 Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2027) 9.4 Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Country 9.4.1 Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2016-2021) 9.4.2 Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size (2016-2027) 10.2 Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Type 10.2.1 Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2027) 10.3 Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Application 10.3.1 Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2027) 10.4 Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Country 10.4.1 Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Roche 11.1.1 Roche Company Details 11.1.2 Roche Business Overview 11.1.3 Roche Varicella-Zoster Virus (VZV) Treatment Introduction 11.1.4 Roche Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) 11.1.5 Roche Recent Development 11.2 Merck 11.2.1 Merck Company Details 11.2.2 Merck Business Overview 11.2.3 Merck Varicella-Zoster Virus (VZV) Treatment Introduction 11.2.4 Merck Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) 11.2.5 Merck Recent Development 11.3 Pfizer 11.3.1 Pfizer Company Details 11.3.2 Pfizer Business Overview 11.3.3 Pfizer Varicella-Zoster Virus (VZV) Treatment Introduction 11.3.4 Pfizer Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) 11.3.5 Pfizer Recent Development 11.4 Novartis 11.4.1 Novartis Company Details 11.4.2 Novartis Business Overview 11.4.3 Novartis Varicella-Zoster Virus (VZV) Treatment Introduction 11.4.4 Novartis Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) 11.4.5 Novartis Recent Development 11.5 Abbott 11.5.1 Abbott Company Details 11.5.2 Abbott Business Overview 11.5.3 Abbott Varicella-Zoster Virus (VZV) Treatment Introduction 11.5.4 Abbott Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) 11.5.5 Abbott Recent Development 11.6 GlaxoSmithKline 11.6.1 GlaxoSmithKline Company Details 11.6.2 GlaxoSmithKline Business Overview 11.6.3 GlaxoSmithKline Varicella-Zoster Virus (VZV) Treatment Introduction 11.6.4 GlaxoSmithKline Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) 11.6.5 GlaxoSmithKline Recent Development 11.7 Sanofi 11.7.1 Sanofi Company Details 11.7.2 Sanofi Business Overview 11.7.3 Sanofi Varicella-Zoster Virus (VZV) Treatment Introduction 11.7.4 Sanofi Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) 11.7.5 Sanofi Recent Development 11.8 Eli Lilly 11.8.1 Eli Lilly Company Details 11.8.2 Eli Lilly Business Overview 11.8.3 Eli Lilly Varicella-Zoster Virus (VZV) Treatment Introduction 11.8.4 Eli Lilly Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) 11.8.5 Eli Lilly Recent Development 11.9 Astrazeneca 11.9.1 Astrazeneca Company Details 11.9.2 Astrazeneca Business Overview 11.9.3 Astrazeneca Varicella-Zoster Virus (VZV) Treatment Introduction 11.9.4 Astrazeneca Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) 11.9.5 Astrazeneca Recent Development 11.10 Johnson & Johnson 11.10.1 Johnson & Johnson Company Details 11.10.2 Johnson & Johnson Business Overview 11.10.3 Johnson & Johnson Varicella-Zoster Virus (VZV) Treatment Introduction 11.10.4 Johnson & Johnson Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) 11.10.5 Johnson & Johnson Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Varicella-Zoster Virus (VZV) Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Acyclovir Table 3. Key Players of Valacyclovir Table 4. Key Players of Famciclovir Table 5. Key Players of Others Table 6. Global Varicella-Zoster Virus (VZV) Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Varicella-Zoster Virus (VZV) Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Varicella-Zoster Virus (VZV) Treatment Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Varicella-Zoster Virus (VZV) Treatment Market Share by Regions (2016-2021) Table 10. Global Varicella-Zoster Virus (VZV) Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Varicella-Zoster Virus (VZV) Treatment Market Share by Regions (2022-2027) Table 12. Varicella-Zoster Virus (VZV) Treatment Market Trends Table 13. Varicella-Zoster Virus (VZV) Treatment Market Drivers Table 14. Varicella-Zoster Virus (VZV) Treatment Market Challenges Table 15. Varicella-Zoster Virus (VZV) Treatment Market Restraints Table 16. Global Varicella-Zoster Virus (VZV) Treatment Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Varicella-Zoster Virus (VZV) Treatment Market Share by Players (2016-2021) Table 18. Global Top Varicella-Zoster Virus (VZV) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Varicella-Zoster Virus (VZV) Treatment as of 2020) Table 19. Ranking of Global Top Varicella-Zoster Virus (VZV) Treatment Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Varicella-Zoster Virus (VZV) Treatment Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Varicella-Zoster Virus (VZV) Treatment Product Solution and Service Table 23. Date of Enter into Varicella-Zoster Virus (VZV) Treatment Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2021) (US$ Million) Table 26. Global Varicella-Zoster Virus (VZV) Treatment Revenue Market Share by Type (2016-2021) Table 27. Global Varicella-Zoster Virus (VZV) Treatment Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Varicella-Zoster Virus (VZV) Treatment Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Varicella-Zoster Virus (VZV) Treatment Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Varicella-Zoster Virus (VZV) Treatment Revenue Market Share by Application (2016-2021) Table 31. Global Varicella-Zoster Virus (VZV) Treatment Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Varicella-Zoster Virus (VZV) Treatment Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2021) (US$ Million) Table 34. North America Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2021) (US$ Million) Table 36. North America Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2022-2027) & (US$ Million) Table 63. Roche Company Details Table 64. Roche Business Overview Table 65. Roche Varicella-Zoster Virus (VZV) Treatment Product Table 66. Roche Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) & (US$ Million) Table 67. Roche Recent Development Table 68. Merck Company Details Table 69. Merck Business Overview Table 70. Merck Varicella-Zoster Virus (VZV) Treatment Product Table 71. Merck Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) & (US$ Million) Table 72. Merck Recent Development Table 73. Pfizer Company Details Table 74. Pfizer Business Overview Table 75. Pfizer Varicella-Zoster Virus (VZV) Treatment Product Table 76. Pfizer Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) & (US$ Million) Table 77. Pfizer Recent Development Table 78. Novartis Company Details Table 79. Novartis Business Overview Table 80. Novartis Varicella-Zoster Virus (VZV) Treatment Product Table 81. Novartis Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) & (US$ Million) Table 82. Novartis Recent Development Table 83. Abbott Company Details Table 84. Abbott Business Overview Table 85. Abbott Varicella-Zoster Virus (VZV) Treatment Product Table 86. Abbott Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) & (US$ Million) Table 87. Abbott Recent Development Table 88. GlaxoSmithKline Company Details Table 89. GlaxoSmithKline Business Overview Table 90. GlaxoSmithKline Varicella-Zoster Virus (VZV) Treatment Product Table 91. GlaxoSmithKline Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) & (US$ Million) Table 92. GlaxoSmithKline Recent Development Table 93. Sanofi Company Details Table 94. Sanofi Business Overview Table 95. Sanofi Varicella-Zoster Virus (VZV) Treatment Product Table 96. Sanofi Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) & (US$ Million) Table 97. Sanofi Recent Development Table 98. Eli Lilly Company Details Table 99. Eli Lilly Business Overview Table 100. Eli Lilly Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) & (US$ Million) Table 101. Eli Lilly Recent Development Table 102. Astrazeneca Company Details Table 103. Astrazeneca Business Overview Table 104. Astrazeneca Varicella-Zoster Virus (VZV) Treatment Product Table 105. Astrazeneca Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) & (US$ Million) Table 106. Astrazeneca Recent Development Table 107. Johnson & Johnson Company Details Table 108. Johnson & Johnson Business Overview Table 109. Johnson & Johnson Varicella-Zoster Virus (VZV) Treatment Product Table 110. Johnson & Johnson Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) & (US$ Million) Table 111. Johnson & Johnson Recent Development Table 112. Research Programs/Design for This Report Table 113. Key Data Information from Secondary Sources Table 114. Key Data Information from Primary Sources List of Figures Figure 1. Global Varicella-Zoster Virus (VZV) Treatment Market Share by Type: 2020 VS 2027 Figure 2. Acyclovir Features Figure 3. Valacyclovir Features Figure 4. Famciclovir Features Figure 5. Others Features Figure 6. Global Varicella-Zoster Virus (VZV) Treatment Market Share by Application: 2020 VS 2027 Figure 7. Hospital Pharmacies Case Studies Figure 8. Retail Pharmacies Case Studies Figure 9. Online Pharmacies Case Studies Figure 10. Varicella-Zoster Virus (VZV) Treatment Report Years Considered Figure 11. Global Varicella-Zoster Virus (VZV) Treatment Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Varicella-Zoster Virus (VZV) Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Varicella-Zoster Virus (VZV) Treatment Market Share by Regions: 2020 VS 2027 Figure 14. Global Varicella-Zoster Virus (VZV) Treatment Market Share by Regions (2022-2027) Figure 15. Global Varicella-Zoster Virus (VZV) Treatment Market Share by Players in 2020 Figure 16. Global Top Varicella-Zoster Virus (VZV) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Varicella-Zoster Virus (VZV) Treatment as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Varicella-Zoster Virus (VZV) Treatment Revenue in 2020 Figure 18. Global Varicella-Zoster Virus (VZV) Treatment Revenue Market Share by Type (2016-2021) Figure 19. Global Varicella-Zoster Virus (VZV) Treatment Revenue Market Share by Type (2022-2027) Figure 20. North America Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Varicella-Zoster Virus (VZV) Treatment Market Share by Type (2016-2027) Figure 22. North America Varicella-Zoster Virus (VZV) Treatment Market Share by Application (2016-2027) Figure 23. North America Varicella-Zoster Virus (VZV) Treatment Market Share by Country (2016-2027) Figure 24. United States Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Varicella-Zoster Virus (VZV) Treatment Market Share by Type (2016-2027) Figure 28. Europe Varicella-Zoster Virus (VZV) Treatment Market Share by Application (2016-2027) Figure 29. Europe Varicella-Zoster Virus (VZV) Treatment Market Share by Country (2016-2027) Figure 30. Germany Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Share by Type (2016-2027) Figure 38. Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Share by Application (2016-2027) Figure 39. Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Share by Region (2016-2027) Figure 40. China Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Varicella-Zoster Virus (VZV) Treatment Market Share by Type (2016-2027) Figure 48. Latin America Varicella-Zoster Virus (VZV) Treatment Market Share by Application (2016-2027) Figure 49. Latin America Varicella-Zoster Virus (VZV) Treatment Market Share by Country (2016-2027) Figure 50. Mexico Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Share by Type (2016-2027) Figure 54. Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Share by Application (2016-2027) Figure 55. Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Share by Country (2016-2027) Figure 56. Turkey Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Roche Revenue Growth Rate in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) Figure 60. Merck Revenue Growth Rate in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) Figure 61. Pfizer Revenue Growth Rate in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) Figure 62. Novartis Revenue Growth Rate in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) Figure 63. Abbott Revenue Growth Rate in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) Figure 64. GlaxoSmithKline Revenue Growth Rate in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) Figure 65. Sanofi Revenue Growth Rate in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) Figure 66. Eli Lilly Revenue Growth Rate in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) Figure 67. Astrazeneca Revenue Growth Rate in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) Figure 68. Johnson & Johnson Revenue Growth Rate in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) Figure 69. Bottom-up and Top-down Approaches for This Report Figure 70. Data Triangulation Figure 71. Key Executives Interviewed

Roche Merck Pfizer Novartis Abbott GlaxoSmithKline Sanofi Eli Lilly Astrazeneca Johnson & Johnson